<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Dsm-firmenich Ag — News on 6ix</title>
    <link>https://6ix.com/company/dsm-firmenich-ag</link>
    <description>Latest news and press releases for Dsm-firmenich Ag on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 26 Feb 2026 06:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/dsm-firmenich-ag" rel="self" type="application/rss+xml" />
    <item>
      <title>dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-cancels-its-shares-following-completion-of-its-euro108-billion-share-repurchase-program-1</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-cancels-its-shares-following-completion-of-its-euro108-billion-share-repurchase-program-1</guid>
      <pubDate>Thu, 26 Feb 2026 06:00:00 GMT</pubDate>
      <description>Press Release dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program Kaiseraugst (Switzerland), Maastricht (Netherlands), February 26 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announces that following the completion of its €1.08 billion share buyback program in 2025, the company has cancelled 12,049,441 shares. As a result, the total number of issued shares has been reduced by approximately 4.5%, from 265,676,388 to 253,626,947</description>
    </item>
    <item>
      <title>dsm-firmenich publishes 2025 Integrated Annual Report</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-publishes-2025-integrated-annual-report-1</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-publishes-2025-integrated-annual-report-1</guid>
      <pubDate>Fri, 20 Feb 2026 06:00:00 GMT</pubDate>
      <description>Press Release dsm-firmenich publishes 2025 Integrated Annual Report Kaiseraugst (Switzerland), Maastricht (Netherlands), February 20, 2026 dsm-firmenich today announces the publication of its Integrated Annual Report (IAR) for 2025, a year during which the company advanced its innovation-led growth agenda, sharpened its strategic profile, and delivered a good performance. The 2025 IAR offers a comprehensive overview of dsm-firmenich’s financial and non-financial progress during the past year. It</description>
    </item>
    <item>
      <title>dsm-firmenich issues €1.5 billion long-term bonds</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-issues-1-5-060000774</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-issues-1-5-060000774</guid>
      <pubDate>Tue, 17 Feb 2026 06:00:00 GMT</pubDate>
      <description>Press Release dsm-firmenich issues €1.5 billion long-term bonds Kaiseraugst (Switzerland), Maastricht (Netherlands), February 17 2026 dsm-firmenich today announces the successful launch of a €1.5 billion dual-tranche bond issuance, consisting of: €750 million 3.00% fixed-rate notes due 2031€750 million 3.75% fixed-rate notes due 2038 The bonds will be issued by DSM B.V. and guaranteed by DSM-Firmenich AG pursuant to the previously established cross-guarantee structure. The proceeds of the new bo</description>
    </item>
    <item>
      <title>dsm-firmenich reports full year 2025 results</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-reports-full-2025-060000332</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-reports-full-2025-060000332</guid>
      <pubDate>Thu, 12 Feb 2026 06:00:00 GMT</pubDate>
      <description>Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), February 12, 2026 dsm-firmenich reports full year 2025 results Management Report 2025 highlights Good financial performance, with strong contribution from synergiesStrategic plan now fully executed following the announced divestment of Animal Nutrition &amp; HealthAnimal Nutrition &amp; Health has been classified as Assets Held for Sale and Discontinued OperationsNew €500 million share repurchase program to be launched in Q1 2026Maintain</description>
    </item>
    <item>
      <title>dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition &amp; Health (ANH)</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-provides-preliminary-comparative-112900395</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-provides-preliminary-comparative-112900395</guid>
      <pubDate>Mon, 09 Feb 2026 11:29:00 GMT</pubDate>
      <description>Annex 1 preliminary comparative figures – restated Annex 1 preliminary comparative figures – restated Annex 1 preliminary comparative figures – reported Annex 1 preliminary comparative figures – reported Press Release dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition &amp; Health (ANH) Kaiseraugst (Switzerland), Maastricht (Netherlands), February 9, 2026 Following the announced divestment of Animal Nutrition &amp; Health (ANH) activities to CVC</description>
    </item>
    <item>
      <title>dsm-firmenich announces agreement to divest Animal Nutrition &amp; Health to CVC Capital Partners</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-announces-agreement-divest-060000477</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-announces-agreement-divest-060000477</guid>
      <pubDate>Mon, 09 Feb 2026 06:00:00 GMT</pubDate>
      <description>Press Release dsm-firmenich announces agreement to divest Animal Nutrition &amp; Health to CVC Capital Partners Kaiseraugst (Switzerland), Maastricht (Netherlands), February 9, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, today announces it has entered into an agreement with CVC, a leading global private markets manager, to divest its Animal Nutrition &amp; Health (“ANH”) business for an enterprise value of about €2.2 billion, which includes an earnout of up to €0.5 billion. dsm-firm</description>
    </item>
    <item>
      <title>dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-appoints-nikeisha-van-060000442</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-appoints-nikeisha-van-060000442</guid>
      <pubDate>Wed, 14 Jan 2026 06:00:00 GMT</pubDate>
      <description>Press Release dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer Kaiseraugst (Switzerland), Maastricht (Netherlands), January 14, 2026 dsm-firmenich, the leading innovator in nutrition, health, and beauty, today announces the appointment of Nikeisha van Sleeuwen as Chief Human Resources Officer (CHRO). Effective April 1, 2026, she will report directly to Dimitri de Vreeze, dsm-firmenich’s Chief Executive Officer, and will serve as a member of the Executive Committee. S</description>
    </item>
    <item>
      <title>dsm-firmenich completes €1.08 billion share repurchase program</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-completes-1-08-213000881</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-completes-1-08-213000881</guid>
      <pubDate>Tue, 02 Dec 2025 21:30:00 GMT</pubDate>
      <description>Press Release dsm-firmenich completes €1.08 billion share repurchase program Kaiseraugst (Switzerland), Maastricht (Netherlands), December 2, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announces it has completed its share repurchase program for a value of €1.08 billion, ahead of the expected completion at the end of January 2026. On February 13, 2025, dsm-firmenich announced its intention to repurchase ordinary shares with an aggregate market value of €1 billion and reduce</description>
    </item>
    <item>
      <title>Weekly progress on share repurchase program to cover share plans and reduce capital</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/weekly-progress-share-repurchase-program-060000696</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/weekly-progress-share-repurchase-program-060000696</guid>
      <pubDate>Tue, 25 Nov 2025 06:00:00 GMT</pubDate>
      <description>Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), November 25, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 13, 2025 its intention to repurchase ordinary shares with an aggregate market value of €1 billion and reduce its issued capital, starting with an initial €500 million. On April 1, 2025, the company commenced a program to repurchase ordinary shares f</description>
    </item>
    <item>
      <title>dsm-firmenich Q3 2025 trading update</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-q3-2025-trading-060000309</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-q3-2025-trading-060000309</guid>
      <pubDate>Thu, 30 Oct 2025 06:00:00 GMT</pubDate>
      <description>Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), October 30, 2025 dsm-firmenich Q3 2025 trading update Management Report Q3 2025 highlights Solid growth and strong step up in Adjusted EBITDA on a comparable basis1Advancing well on 2025 strategic planAnimal Nutrition &amp; Health (‘ANH’) exit process ongoingFY 2025 outlook updated for foreign exchange and ANH-related vitamin volatility: Adjusted EBITDA of around €2.3 billion Key figures in € millionsQ3 YTD 2025Q3 YTD 2024% ChangeQ3 2</description>
    </item>
    <item>
      <title>dsm-firmenich achieves target of 100% purchased renewable electricity</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-achieves-target-100-050000887</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-achieves-target-100-050000887</guid>
      <pubDate>Wed, 03 Sep 2025 05:00:00 GMT</pubDate>
      <description>Press Release dsm-firmenich achieves target of 100% purchased renewable electricity Kaiseraugst (Switzerland), Maastricht (Netherlands), September 3, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, today announces that it has achieved its 2025 goal of sourcing 100% of purchased electricity from renewable sources, several months ahead of target. This marks a milestone in the company’s strategy to reach net-zero greenhouse gas (GHG) emissions across its operations and value chain</description>
    </item>
    <item>
      <title>dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-strengthens-executive-committee-050000602</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-strengthens-executive-committee-050000602</guid>
      <pubDate>Mon, 01 Sep 2025 05:00:00 GMT</pubDate>
      <description>Bio photos Bio photos of Alessandre Keller, Philip Eykerman, Maurizio Clementi, and Patrick Niels. Press Release dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company Kaiseraugst (Switzerland), Maastricht (Netherlands), September 1, 2025 dsm-firmenich is entering a new chapter, accelerating its transformation into a fully consumer-focused company, and strengthening its position as a leading creation and innovation partner in nutrition, health, and beau</description>
    </item>
    <item>
      <title>dsm-firmenich reports H1 2025 results</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-reports-h1-2025-050000248</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-reports-h1-2025-050000248</guid>
      <pubDate>Thu, 31 Jul 2025 05:00:00 GMT</pubDate>
      <description>Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), July 31, 2025 dsm-firmenich reports H1 2025 results Management Report H1 2025 highlights Good first half of the year, with good organic sales and earnings growthProgressing well on 2025 strategic planCompletion of sale of Feed Enzymes business for €1.5 billion on June 2, 2025€1 billion share buyback program commenced in April 2025, and completion accelerated to January 2026Animal Nutrition &amp; Health exit process advancingFY 2025 ou</description>
    </item>
    <item>
      <title>dsm-firmenich announces redemption of €750 million hybrid bond</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-announces-redemption-750-050000815</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-announces-redemption-750-050000815</guid>
      <pubDate>Tue, 01 Jul 2025 05:00:00 GMT</pubDate>
      <description>Press Release dsm-firmenich announces redemption of €750 million hybrid bond Kaiseraugst (Switzerland), Maastricht (Netherlands), July 1, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, has decided to call and redeem the €750 million Deeply Subordinated Fixed Rate Resettable Perpetual Loan Notes (the “hybrid bond”) issued on May 27, 2020 (XS2182055009) by Firmenich International SA (the “Issuer”), a direct subsidiary of DSM-Firmenich A.G. The €750 million hybrid bond, with a cou</description>
    </item>
    <item>
      <title>dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-announces-increase-share-050000432</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-announces-increase-share-050000432</guid>
      <pubDate>Fri, 27 Jun 2025 05:00:00 GMT</pubDate>
      <description>Press Release dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion Kaiseraugst (Switzerland), Maastricht (Netherlands), June 27, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 13, 2025 its intention to repurchase ordinary shares with an aggregate market value of €1 billion and reduce its issued capital. This share repurchase program started for an initial €500 million and will now be increased to €1 billion, followin</description>
    </item>
    <item>
      <title>dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-completes-sale-stake-111300547</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-completes-sale-stake-111300547</guid>
      <pubDate>Mon, 02 Jun 2025 11:13:00 GMT</pubDate>
      <description>Press Release dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion Kaiseraugst (Switzerland), Maastricht (Netherlands), June 2, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, today announces the successful completion of the sale of its stake in the Feed Enzymes Alliance to its partner Novonesis, a global leader in biosolutions, for €1.5 billion. The sale agreement was announced on February 11, 2025. dsm-firmenich received approximatel</description>
    </item>
    <item>
      <title>DSFIY - Books will close today, May 8, 2025</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsfiy-books-will-close-today-may-8-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsfiy-books-will-close-today-may-8-2025</guid>
      <pubDate>Thu, 08 May 2025 12:42:44 GMT</pubDate>
      <description>DSFIY - Books will close today, May 8, 2025.</description>
    </item>
    <item>
      <title>dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-shareholders-approve-resolutions-103400141</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-shareholders-approve-resolutions-103400141</guid>
      <pubDate>Tue, 06 May 2025 10:34:00 GMT</pubDate>
      <description>Press Release dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025 Kaiseraugst (Switzerland), Maastricht (Netherlands), May 6, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announces that its shareholders approved all proposals of the Board of Directors at its Annual General Meeting today, including the Management Report, the consolidated financial statements as well as the Sustainability Report 2024. Key highlights include: Thomas Leysen was re-el</description>
    </item>
    <item>
      <title>dsm-firmenich Q1 2025 trading update</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-q1-2025-trading-050000792</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/dsm-firmenich-q1-2025-trading-050000792</guid>
      <pubDate>Wed, 30 Apr 2025 05:00:00 GMT</pubDate>
      <description>Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), April 30, 2025 dsm-firmenich Q1 2025 trading update Management Report Q1 2025 highlights Good start to the year with strong organic sales and earnings growthProgressing well on 2025 strategic planSale of Feed Enzymes business for €1.5 billion announcedAnimal Nutrition &amp; Health exit process advancing as planned€1 billion share buyback program commenced in AprilFY 2025 outlook unchanged: Adjusted EBITDA at least €2.4 billion Key fig</description>
    </item>
    <item>
      <title>Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich</title>
      <link>https://6ix.com/company/dsm-firmenich-ag/news/laetitia-pictet-appointed-chief-legal-050000429</link>
      <guid isPermaLink="true">https://6ix.com/company/dsm-firmenich-ag/news/laetitia-pictet-appointed-chief-legal-050000429</guid>
      <pubDate>Tue, 08 Apr 2025 05:00:00 GMT</pubDate>
      <description>Press Release Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich Kaiseraugst (Switzerland), Maastricht (Netherlands), April 8, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, is pleased to announce the appointment of Laetitia Pictet as Chief Legal, Risk and Compliance Officer (CLRCO), effective May 1, 2025. She succeeds Jane Sinclair, who is retiring after a distinguished career. Laetitia Pictet brings over 25 years of senior legal expertise acro</description>
    </item>
  </channel>
</rss>